However, in mice, hepatic SOCS3 deficiency was found to enhance hepatic insulin sensitivity but paradoxically promotes NAFLD and inflammation in a hypertrophic environment with high glucose and fatty acids [28]. Here, SOCS3 is linked to metabolic dysfunction-associated steatotic liver disease.